Eurofins Clinical Trial Solutions’ Post

View organization page for Eurofins Clinical Trial Solutions, graphic

7,275 followers

In an recent interview with SelectScience®, study author Karina Eterovic, MSc, PhD, NYS CoQ, R&D Director of Oncology Diagnostics at Eurofins Viracor BioPharma Services, discussed the complex interplay between clonal hematopoiesis (CH) and cancer genomics, in the context of precision of oncology therapy development, cancer diagnosis and treatment. She shared the results of a recent study that emphasize the potential need to integrate routine germline sequencing into clinical practice to prevent the misclassification of CH aberrations. Findings identified somatic CH mutations in a substantial subset of patients with advanced solid tumors. This has implications for accurate treatment decisions in cancer patients, as distinguishing between tumor-derived mutations and CH mutations is crucial. Read more here: https://lnkd.in/ezM6KXWx #onocologyresearch #cancer #genomics #eurofins #testingforlife #biopharma Eurofins Bioanalytical Services Eurofins Central Laboratory Eurofins Clinical Trial Supplies

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics